Mechanisms and structural determinants of HIV-1 coat protein, gp41- induced neurotoxicity

Journal of Neuroscience

Volumn 19, Issue 1, 1999, Pages 64-71

  Adamson, D Cory ^a   Kopnisky, Kathy L ^a   Dawson, Ted M ^a   Dawson, Valina L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gp41; HIV 1; HIV associated dementia; Immunological nitric oxide synthase; Neurotoxicity; Nitric oxide

Indexed keywords

CELL SURFACE RECEPTOR; COAT PROTEIN; CYTOKINE; GLYCOPROTEIN GP 41; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL DEATH; CRYSTAL STRUCTURE; DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RAT;

EID: 0032930241     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-01-00064.1999     Document Type: Article

References (49)

1. Adamson DC, Dawson TM, Zink MC, Clements JE, Dawson VL (1996a) Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial and glial apoptosis. Mol Med 2:417-428.
2. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL (1996b) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 coat protein, gp41. Science 274:1917-1921.
3. Adamson DC, McArthur JC, Dawson TM, Dawson VL (1999) Course of HIV-associated dementia: correlations with gp41, iNOS and macropnage/microglial activation. Mol Med, in press.
4. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: a RANTES, MIP-lalpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
5. Barcova M, Kacani L, Speth C, Dierich MP (1998) gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production. J Infect Dis 177:905-913.
6. Bird C, Burke J, Gleeson PA, McCluskey J (1990) Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells. J Biol Chem 265:19151-19157.
7. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639-642.
8. Chan DC, Fass D, Berger JM, Kim PS (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
9. Dawson VL, Dawson TM, Uhl GR, Snyder SH (1993) Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90:3256-3259.
10. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 16:2479-2487.
11. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
12. Dickson DW, Belman AL, Park YD, Wiley C, Horoupian DS, Llena J, Kure K, Lyman WD, Morecki R, Mitsudo S (1989) Central nervous system pathology in pediatric AIDS: an autopsy study. APMIS [Suppl] 8:40-57.
13. Dickson DW, Lee SC, Mattiace LA, Yen SC, Brosnan C (1993) Microglia and cytokines in neurologic disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
14. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
15. Earl PL, Moss B, Doms RW (1991) Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J Virol 65:2047-2055.
16. Everall IP, Luthert PJ, Lantos PL (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337:1119-1121.
17. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38:755-762.
18. Gonzalez-Zulueta M. Ensz LM, Mukhina G, Lebovitz RM, Zwacka RM, Engelhardt JF, Oberley LW, Dawson VL, Dawson TM (1998) Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J Neurosci 18:2040-2055.
19. Haseltine WA (1989) Development of antiviral drugs for the treatment of AIDS: strategies and prospects. J Acquir Immune Defic Syndr Hum Retrovirol 2:311-334.
20. Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 603:222-233.
21. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK (1992) Epidemiology of human immunodeficiency virus versus encephalopathy in the United States. Neurology 42:1472-1476.
22. Kliger Y, Aharoni A, Rapaport D, Jones P, Blumenthal R, Shai Y (1997) Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study. J Biol Chem 272:13496-13505.
23. Koka P, He K, Camerini D, Tran T, Yashar SS, Merrill JE (1995a) The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells. J Neuroimmunol 57:179-191.
24. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE (1995b) Human immunodeficiency virus type 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 182:941-951.
25. Kure K, Lyman WD, Weidenheim KM, Dickson DW (1990a) Cellular localization of an HIV-1 antigen in subactute AIDS encephalitis using an improved double-labelling immunohistochemistry method. Am J Pathol 136:1085-1092.
26. Kure K, Weidenheim KM, Lyman WD, Dickson DW (1990b) Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 80:393-400.
27. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-118.
28. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA (1992) Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 66:285-291.
29. Merrill JE, Chen ISY (1991) HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 5:2391-2396.
30. Merrill JE. Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS (1992) Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 66:2217-2225.
31. Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: 1. Clinical features. Ann Neurol 19:517-524.
32. Nuovo GJ, Alfieri ML (1996) AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 2:358-366.
33. Perrin C, Fenouillet E, Jones IM (1998) Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein. Virology 242:338-345.
34. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592.
35. Rosenblum M (1990) Infection of the central nervous system by the human immunodeficiency virus type 1. Pathobiol Annu 25:117-169.
36. Rostasy K, Monti L, Kneissl M, Bell J, Hedreen J, Navia B (1998) Proinflammatory mediators and HIV infection in the basal ganglia: their pathogenetic relationship to the AIDS dementia complex. Neuroscience of HIV Infection 1:30
37. Sabatier J, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, Bahraoui E (1991) Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 65:961-967.
38. Samdani AF, Newcamp C, Resink A, Facchinetti F, Hoffman BE, Dawson VL, Dawson TM (1997) Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. J Neurosci 17:4633-4641.
39. Seilhean D, Kobayashi K, He Y, Uchihara T, Rosenblum O, Katlama C, Bricaire F. Duyckaerts C, Hauw JJ (1997) Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol (Berl) 93:508-517.
40. Toggas SM, Masliah E, Rockenstein EM, Rail GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
41. Watkins BA, Dorn HH, Kelly WB, Armstrong RC, Potts BJ. Michaels F, Kufta CV, Dubois-Dalcq M (1990) Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249:549-553.
42. Werner T, Ferroni S, Saermark T, Brack-Werner R, Banati RB, Mager R, Steinaa L, Kreutzberg GW, Erfle V (1991) HIV-1 nef protein exhibits structural and functional similarity to scorpion peptidcs interacting with K+ channels. AIDS 5:1301-1308.
43. Wesselingh S, Power C, Glass J, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE (1993) Intracerebral cytokine mRNA expression in AIDS dementia. Ann Neurol 33:576-582.
44. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089-7093.
45. Wiley CA, Masliah E. Morcy M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991) Neocortical damage during HIV infection. Ann Neurol 29:651-657.
46. Willey RL, Bonifacino JS, Potts BJ, Martin MA, Klausner RD (1988) Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci USA 85:9580-9584.
47. Willey RL, Shibata R, Freed EO, Cho MW, Martin MA (1996) Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J Virol 70:6431-6436.
48. Zhang L, Huang Y, He T, Cao Y, Ho DD (1996) HIV-1 subtype and second-receptor use. Nature 383:768.
49. Zink MC, Amedee AM, Mankowski JL, Craig L, Didier P, Carter DL, Munoz A, Murphey-Cobb M, Clements JE (1997) Pathogenesis of SIV encephalitis: selection and replication of neurovirulent SIV. Am J Pathol 151:793-803.